Food And Drug Administration

Center For Biologics Evaluation And Research

Vaccines And Related Biological Products Advisory Committee Meeting

Wednesday, December 14 - 15, 2005

Holiday Inn Select, 8120 Wisconsin Ave., Bethesda, MD 20814

 

AGENDA

 

 

Day 1

         

Open Session

 

9:00 a.m.         Call to Order and Opening Remarks            Gary D. Overturf, M.D., Chair

 

9:05                 Presentation of Appreciation Plaques to                Norman W. Baylor, Ph.D., FDA

                        Retiring Members                                             

 

 9:10                Administrative Matters                                       Christine Walsh, R.N., FDA

 

Safety and Efficacy of Rotavirus Vaccine Manufactured by Merck

 

9:20 a.m.          FDA Brief Introduction                                 Rosemary Tiernan, M.D., M.P.H., FDA

Presentation of Questions

 

9:30                 Sponsor Presentation                                                 Mark Bagarazzi, M.D./

                                                                                                   Penny Heaton, M.D., M.P.H.

                                                                                                   Merck Research Laboratories

 

10:30               Break

 

10:45               FDA Presentation                                             Rosemary Tiernan, M.D., M.P.H., FDA

                                                                                                   Hector Izurieta, M.D., M.P.H., FDA

11:45               Lunch

 

1:15 p.m. Open Public Hearing

 

1:45                 FDA Presentation of Questions            Rosemary Tiernan, M.D., M.P.H., FDA

 

2:00                 Committee Discussion of FDA Questions

       Committee Recommendations

 

4:30 p.m.            Adjourn for the day

 

 

 

 

 

 

 

Food And Drug Administration

Center For Biologics Evaluation And Research

Vaccines And Related Biological Products Advisory Committee Meeting

Wednesday, December 14 - 15, 2005

Holiday Inn Select, 8120 Wisconsin Ave., Bethesda, MD 20814

 

AGENDA

 

 

Day 2

         

Open Session

 

9:00 a.m.         Call to Order and Opening Remarks         Gary D. Overturf, M.D., Chair 

9:05                 Administrative Matters                                    Christine Walsh, R.N., FDA

 

Safety and Efficacy of ZOSTAVAX (Zoster Vaccine Live [Oka/Merck] ) Manufactured by Merck

 

9:20 a.m.             FDA Brief Introduction                              Patricia Rohan, M.D., FDA

Presentation of Questions

 

9:30                 Sponsor Presentation                                              David Gutsch, M.D./

                                                                                                Jeffrey Silber, M.D.

                                                                                                Merck Research Laboratories

 

10:45               Break

 

11:00               FDA Presentation                                         Patricia Rohan, M.D., FDA

 

12 noon            Lunch

 

1:30 p.m. Open Public Hearing

 

2:00            FDA Presentation of Questions            Patricia Rohan, M.D., FDA

 

2:15                 Committee Discussion of FDA Questions

       Committee Recommendations

 

4:30 p.m.            Adjourn meeting